Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUropean Pharmacogenetics of AntiCoagulation Therapy (phenprocoumon/acenocoumarol) trial
2009-016992-31Phase 4Active
- Sponsor
- Democritus University of Thrace Medical School
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acenocoumarol and phenprocoumon in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by Democritus University of Thrace Medical School. Primary endpoint: Percent time in therapeutic INR range. Started Dec 2009; status: active.
02
Drugs
acenocoumarolphenprocoumon
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2009-016992-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016992-31.